Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting ...

Leerink Global Healthcare Conference 2025 March 10, 2025 11:20 AM ETCompany ParticipantsAlisha Alaimo - President of ...

Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...

SLN ("Silence" or the "Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, ...

A live webcast will be available on the Alumis website in the "Investors" section under the “Events” page.

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that Capricor management ...

On Tuesday, 11 March 2025, Revvity Inc. (NYSE: RVTY) presented at the Leerink Global Healthcare Conference 2025, outlining its strategic resilience amidst current economic challenges. The company ...

will participate in a fireside chat at Leerink's 2025 Global Healthcare Conference on Tuesday, March 11, 2025 at 10:40 am ET. A live webcast will be available on the Alumis website in the ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two ...

today announced that members of the Company’s management team will present at Leerink’s Global Healthcare Conference: MindMed is a late-stage clinical biopharmaceutical company developing ...

Mark Grasso, Chief Financial Officer, Elektor: Good morning, everyone. And thanks to Mark and the Leerink team for having us today. I’m Mark Grasso. I’m the chief financial officer at Elektor ...

announced that its management will present at the Leerink Partners 2025 Global Healthcare Conference on March 10, 2025, in Miami, FL, at 4:20 PM ET. During the conference, they will also conduct ...